1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Part of paid clinical trials in Elmsford, New York.

Sponsor
Montefiore Medical Center
Study ID
NCT05460611
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Accepted

Interventions

  • Sciton HALO 1470nm Non-ablative laser — DEVICE
    Patients will be treated with the 1470nm non-ablative laser.

Study Details

Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.

Key Dates

Start date
Dec 7, 2023
Status verified
Jun 2026
Primary completion
Jul 31, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
10 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Androgenetic Alopecia
    The parameters of the laser will be set according to optimal operation protocol and in accordance with guidelines set forth by Sciton. Each laser treatment will take approximately 10 to 15 minutes per subject to target androgenetic alopecia.
  • Experimental: Scarring Alopecia
    The parameters of the laser will be set according to optimal operation protocol and in accordance with guidelines set forth by Sciton. Each laser treatment will take approximately 10 to 15 minutes per subject to target scarring alopecia.

Primary Outcome Measure

Live and Photographic assessment of hair loss [ Time Frame: Month 1 (baseline), Month 2, Month 3, Month 6, Month 9, Month 12, Month 15 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Montefiore Einstein Advanced CareElmsfordNew York10523
Gabriela Gjini
[email protected]
914-457-4130

Find similar trials in Elmsford, NY

By research site
Montefiore Einstein Advanced Care· Elmsford, NY

Related Studies